Taken together, our results demonstrated that CD38 deficiency protected mice from HFD-induced NAFLD through activating Sirtuins/PPARα/SOD2 signaling pathway. The gene discussed is CD38; the disease is metabolic dysfunction-associated steatotic liver disease.